Edit joined the company in 2000 and has worked in both the UK and Hungarian offices. She holds a master’s degree in finance from the Budapest University of Economic Sciences, Hungary, a master’s in health economics (with distinction) from the University of York, UK, and has completed her PhD in health economics at the Health Economics Research Group, Brunel University, UK.
In her role at Evidera, Edit has worked in the areas of oncology, cardiovascular disease, medical devices, epilepsy, and psychiatric illnesses, including schizophrenia, ADHD, and depression. Her main areas of interest are quantitative decision analysis and modeling. She has experience in developing many different model types (cohort and patient level simulation models) serving different aims (cost-effectiveness models, budget impact models, pricing models) for a multitude of audiences (regulatory bodies, expert communities, internal decision makers). Edit has been involved in the preparation of a number of submissions of evidence to the National Institute for Health and Clinical Excellence and similar bodies in other countries. Her responsibilities have also included coordinating multinational studies, and she has a deep understanding of the differing requirements for health technology assessment in many countries.
Edit has published in journals such as the Journal of Clinical Oncology, European Journal of Health Economics, British Journal of Cancer, and Journal of Medical Economics.